Group One Trading’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.83M | Buy |
10,600
+9,000
| +563% | +$2.1M | ﹤0.01% | 1893 |
|
|
2026
Q1 | $366K | Buy |
1,600
+100
| +7% | +$22.4K | ﹤0.01% | 3623 |
|
|
2025
Q4 | $320K | Sell |
1,500
-4,900
| -77% | -$1.01M | ﹤0.01% | 3948 |
|
|
2025
Q3 | $1.27M | Buy |
6,400
+4,100
| +178% | +$765K | ﹤0.01% | 2773 |
|
|
2025
Q2 | $397K | Sell |
2,300
-8,900
| -79% | -$1.45M | ﹤0.01% | 3653 |
|
|
2025
Q1 | $1.75M | Buy |
11,200
+1,300
| +13% | +$186K | 0.01% | 1941 |
|
|
2024
Q4 | $1.36M | Buy |
9,900
+3,200
| +48% | +$421K | ﹤0.01% | 2260 |
|
|
2024
Q3 | $1M | Sell |
6,700
-11,300
| -63% | -$1.53M | ﹤0.01% | 2289 |
|
|
2024
Q2 | $2.45M | Buy |
+18,000
| New | +$2.45M | 0.01% | 1278 |
|
|
2024
Q1 | – | Sell |
-4,600
| Closed | -$579K | – | 7019 |
|
|
2023
Q4 | $579K | Sell |
4,600
-7,700
| -63% | -$768K | ﹤0.01% | 2946 |
|
|
2023
Q3 | $1.15M | Buy |
12,300
+200
| +2% | +$18.7K | ﹤0.01% | 2121 |
|
|
2023
Q2 | $1.08M | Buy |
+12,100
| New | +$1.05M | ﹤0.01% | 2292 |
|
|
2023
Q1 | – | Sell |
-2,800
| Closed | -$342K | – | 7177 |
|
|
2022
Q4 | $342K | Sell |
2,800
-4,700
| -63% | -$546K | ﹤0.01% | 3380 |
|
|
2022
Q3 | $774K | Hold |
7,500
| – | – | ﹤0.01% | 2824 |
|
|
2022
Q2 | $697K | Buy |
7,500
+7,100
| +1,775% | +$669K | ﹤0.01% | 3112 |
|
|
2022
Q1 | $47K | Buy |
400
+200
| +100% | +$23.2K | ﹤0.01% | 6131 |
|
|
2021
Q4 | $27K | Hold |
200
| – | – | ﹤0.01% | 6779 |
|
|
2021
Q3 | $32K | Sell |
200
-700
| -78% | -$95.8K | ﹤0.01% | 6865 |
|
|
2021
Q2 | $118K | Buy |
900
+500
| +125% | +$66.6K | ﹤0.01% | 5796 |
|
|
2021
Q1 | $52K | Buy |
400
+200
| +100% | +$30.4K | ﹤0.01% | 6190 |
|
|
2020
Q4 | $33K | Sell |
200
-5,000
| -96% | -$827K | ﹤0.01% | 5241 |
|
|
2020
Q3 | $802K | Buy |
5,200
+100
| +2% | +$14.4K | ﹤0.01% | 2408 |
|
|
2020
Q2 | $754K | Buy |
5,100
+5,000
| +5,000% | +$686K | ﹤0.01% | 2292 |
|
|
2020
Q1 | $11K | Sell |
100
-100
| -50% | -$13K | ﹤0.01% | 4515 |
|
|
2019
Q4 | $28K | Sell |
200
-800
| -80% | -$88.9K | ﹤0.01% | 4244 |
|
|
2019
Q3 | $96K | Sell |
1,000
-34,900
| -97% | -$3.89M | ﹤0.01% | 3586 |
|
|
2019
Q2 | $4.13M | Buy |
35,900
+9,800
| +38% | +$1.17M | 0.04% | 632 |
|
|
2019
Q1 | $3.07M | Buy |
26,100
+22,700
| +668% | +$1.99M | 0.03% | 670 |
|
|
2018
Q4 | $213K | Buy |
3,400
+3,300
| +3,300% | +$207K | ﹤0.01% | 2637 |
|
|
2018
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 4739 |
|
|
2018
Q2 | $7K | Buy |
+100
| New | +$6.58K | ﹤0.01% | 4706 |
|
Other funds holding ASND
RCM
ACA
JT
Group One Trading's ASND Position: Q2 2026 in Review
Group One Trading opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 4,019 shares worth $1.07M. The stake represents ﹤0.01% of the portfolio and ranks #2807 among its holdings. This is a return to the name: Group One Trading previously reported a position in ASND as recently as Q2 2025.
Group One Trading first reported a position in ASND in Q2 2018 and has held it in 18 quarters since. The position peaked at $1.79M in Q3 2022. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.
- Group One Trading held 4,019 shares of Ascendis Pharma A/S worth $1.07M as of Q2 2026.
- Ascendis Pharma A/S was a new Group One Trading position in Q2 2026.
- Ascendis Pharma A/S made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #2807 holding.
- Group One Trading first reported a position in Ascendis Pharma A/S in Q2 2018 and has held it in 18 quarters since.
- Group One Trading's Ascendis Pharma A/S position peaked at $1.79M in Q3 2022.
- 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.